| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 26.0954 | 40 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 25.4022 | 38 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 23.6668 | 38 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 22.7423 | 36 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 42.1295 | 47 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 33.6738 | 40 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 34.6367 | 44 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 74.3903 | 63 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 47.7139 | 51 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 79.6408 | 64 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 40.8501 | 47 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 28.9273 | 38 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 32.6063 | 39 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 78.9343 | 62 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 42.998 | 50 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 83.1182 | 65 |